1 000+ Regenerative Medicine Industry reports covering 200 countries — revenue data, market shares and forecast 2026-2030.
Global regenerative medicine market forecast to reach $85.5B by 2030, 15.2% CAGR. M&A and client wins consolidating share among top 20 cell and gene therapy firms. Covers income data, infrastructure and segment forecasts for 2026-2030.
North America regenerative medicine market projected at $34.6B by 2030, 15.0% CAGR. Region holds over 40% of global share, led by US-based therapy developers. Report covers market trends and economic analysis through 2030.
US regenerative medicine market valued at $18.9B in 2025, 15.6% CAGR to 2030. Landscape led by established biopharma and 900+ active cell therapy developers. Report covers market size, income data and segment forecasts through 2030.
Asia regenerative medicine market forecast at $38.5B by 2030, growing at 16.4% CAGR. Market share analysis of leading producers across cell, gene and tissue therapies. Includes production data, product launches and partnerships, 2026-2030 outlook.
Europe regenerative medicine market forecast at $19.8B by 2030, 13.9% CAGR. Cross-border M&A and production expansion among leading ATMP manufacturers. Includes production and sales data plus trend forecasts to 2030.
Japan regenerative medicine market sized at $3.2B in 2025, 14.8% CAGR to 2030. Partnerships and M&A between pharma majors and iPSC developers shape the field. Covers income data, deal activity and segment forecasts for 2026-2030.
96%
of our customers give us a high rating on Trustpilot and G2 platforms